NeuroOne regains Nasdaq compliance as bid price holds above $1 for 10 days

NEUROONE MEDICAL TECHNOLOGIES Corp

Received Nasdaq deficiency letter on May 6, 2025 for bid price below $1 for 30 consecutive days.
On April 30, 2026, Nasdaq notified company compliance regained after 10 consecutive days with closing bid price at or above $1.
Matter is closed; the company continues to trade on Nasdaq Capital Market.
No further action or extension required regarding the bid price rule.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.